Report
MedLife SA : Peer-beating growth available at an undemanding valuation
MedLife is an integrated provider of healthcare services in Romania able to accompany the patient across the entire medical journey from prevention to diagnosis to treatments in clinics and hospitals. We expect the company to continue to capitalise on the growth of private healthcare spending in Romania. The current valuation of 9.5x 2026e EV/EBITDA is in line with its peers, while we project EBITDA growth of 16% p.a. until 2027e compared to high single digit growth for peers. We are therefore initiating coverage with an Outperform rating and target price of RON 9.0.
Underlying
Med Life
Provider
Oddo BHF
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Philip Hettich
Other Reports on these Companies
Other Reports from Oddo BHF
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.